Sjogren Syndrome Antigen B (SSB) Peptide
Aperçu rapide pour Sjogren Syndrome Antigen B (SSB) Peptide (ABIN939535)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- ISEDKTKIRR SPSKPLPEVT DEYKNDVKNR SVYIKGFPTD ATLDDIKEWL
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSB antibody,
Alternative Names: SSB control peptide, SSB antibody Blocking Peptide, Anti-SSB Blocking Peptide, Sjogren Syndrome Antigen B Blocking Peptide, Autoantigen La Blocking Peptide, LARP3 Blocking Peptide, La Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- SSB (Sjogren Syndrome Antigen B (SSB))
-
Sujet
- SSB is involved in diverse aspects of RNA metabolism, including binding and protecting 3-prime UUU(OH) elements of newly RNA polymerase III-transcribed RNA, processing 5-prime and 3-prime ends of pre-tRNA precursors, acting as an RNA chaperone, and binding viral RNAs associated with hepatitis C virus. SSB protein was originally defined by its reactivity with autoantibodies from patients with Sjogren syndrome and systemic lupus erythematosus.
-
Poids moléculaire
- 45 kDa
Antigène
-